Use of Recombinant Luteinizing Hormone for Controlled Ovarian Hyperstimulation in Infertile Patients
Overview
Authors
Affiliations
Controlled ovarian stimulation has become an integral part of a high complexity infertility treatment. Treatment options with recombinant gonadotrophins add more to knowledge on folliculogenesis and ovarian steroidogenesis. Therefore, a literature search was conducted in the following data bases: Medline, Scielo and PubMed. The descriptors/ key words used were ovarian stimulation, in vitro fertilization, recombinant luteinizing hormone, supplementation LH. The aim of this study was to review the available literature and to assess the benefits of using recombinant luteinizing hormone associated with recombinant follicle stimulating hormone in different populations who have undergone assisted reproduction procedures.
Huang C, Shi Q, Yan Y, Shen X, Shan H, Zhu Y Int J Womens Health. 2022; 14:1691-1700.
PMID: 36536609 PMC: 9759025. DOI: 10.2147/IJWH.S388726.
Pregnancy confirmed after controlled ovarian stimulation for infertility: A case report.
Jiang M, Wang C, Fei X, Lin Z Medicine (Baltimore). 2021; 100(37):e27140.
PMID: 34664838 PMC: 8447983. DOI: 10.1097/MD.0000000000027140.
Deng Y, Yin M, Liang P, Chen Z, Sun L Nan Fang Yi Ke Da Xue Xue Bao. 2017; 37(11):1501-1505.
PMID: 29180331 PMC: 6779645.